You are here

  • Home
  • Archive
  • Volume 64, Issue Suppl 1
  • PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials

Citation Tools

Article menu
Download PDFPDF
Neurogastroenterology: Functional Disorders, Motility and Clinical Physics
PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Díaz C, Falques M, Vilardell D, et al
PTU-186 Baseline characteristics as a predictor of response to linaclotide (constella®) in patients with irritable bowel syndrome with constipation: a pooled analysis of 2 phase 3 trials
Gut 2015;64:A145.